People

Preethi Sundaram

Pharmaceutical strategy and clinical-development executive appointed to Cilcare’s board on December 2, 2024. The January 2025 announcement describes her Catalyst Pharmaceuticals chief strategy role and earlier Sanofi, Abbott, Covance and Neurovision experience; later tenure has not been independently confirmed.